Related Experiment Video

Updated: Nov 15, 2025

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
08:13

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

22.1K

Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses

Thembi Mdluli, Ningbo Jian, Bonnie Slike

    Plos Pathogens
    |March 2, 2021
    PubMed

    Abstract:

    [This corrects the article DOI: 10.1371/journal.ppat.1009101.].

    More Related Videos

    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
    09:54

    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

    Published on: December 3, 2019

    9.6K
    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    11.2K

    Related Experiment Videos

    Last Updated: Nov 15, 2025

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
    08:13

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

    Published on: January 20, 2019

    22.1K
    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
    09:54

    Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

    Published on: December 3, 2019

    9.6K
    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    11.2K

    Related Concept Videos

    Vaccinations01:51

    Vaccinations

    49.2K
    Overview
    49.2K
    Immune Response Against Viral Pathogens01:29

    Immune Response Against Viral Pathogens

    1.2K
    The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
    NK Cells
    NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
    1.2K

    Articles linked to this work by shared authors, journal, and citation graph.

    NK-like and networked CD8 + T cell immunity mediates exceptional HIV control.

    bioRxiv : the preprint server for biology·2026

    Preserved CD4 + T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapy.

    bioRxiv : the preprint server for biology·2026

    Expansion of stemlike HIV-specific CD8+ T cells and limited viral epitope diversity characterize durable posttreatment control of HIV.

    Science translational medicine·2026

    Non-Clinical Safety of GRAd Vector-Based COVID-19 and HIV Vaccines Supports a Platform Regulatory Approach.

    Vaccines·2026

    Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection.

    Gut·2025

    Family management styles of families of children and adolescents with developmental disabilities during the COVID-19 pandemic: a cross-sectional study.

    Scientific reports·2025

    Correction: Noncanonical bactericidal activity of teleost type I interferon is conferred by a membrane-targeting C-terminal peptide.

    PLoS pathogens·2026

    A global map of the Zika virus phosphoproteome reveals host-driven regulation of viral particle release and cytopathogenicity.

    PLoS pathogens·2026

    EspO-mediated neutrophil accumulation drives lethality during Citrobacter rodentium infection in interleukin-22-deficient mice.

    PLoS pathogens·2026

    Hypervirulence-associated pseudo-compound transposons as fundamental mobile units driving cross-species virulence dissemination in Enterobacteriaceae.

    PLoS pathogens·2026

    Acidic and alkaline conditions enhance Staphylococcus aureus α-toxin pore formation and cytotoxicity.

    PLoS pathogens·2026

    The TRAF6-Akt axis is required for efficient lytic replication of KSHV.

    PLoS pathogens·2026

    Interleukin-39 aggravates sepsis by inducing self-sustaining neutrophil activation in the lungs via the CXCL1-CXCR2 pathway.

    International journal of biological sciences·2026

    Mechanisms and clinical research progress of IL-6-mediated crosstalk between the alveolar microenvironment and the immune system in patients with severe pneumonia undergoing mechanical ventilation.

    Frontiers in immunology·2026

    Roles of IL-34 in neurological diseases: neuroprotection, inflammatory regulation, and myeloid plasticity.

    Frontiers in immunology·2026

    Inflammatory remodeling of the ovarian microenvironment in premature ovarian insufficiency: mechanisms and therapeutic opportunities.

    Frontiers in immunology·2026

    Recent understanding of immunometabolic remodeling in pulmonary macrophages: homeostasis, chronic respiratory diseases, and therapeutic targeting.

    Frontiers in pharmacology·2026

    RAC2 orchestrates immune cell actin remodeling and migration.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us